NCT05120908

Brief Summary

Obesity is a major public health problem related to a variety of illnesses such as heart disease and diabetes. Prior research indicates that social stressors contribute to risk for obesity, possibly through alterations in diet and physical activity. However, it is not fully clear how these alterations contribute to obesity. The purpose of this study is to examine how the stressors of social isolation and discrimination relate to eating behaviors and dietary patterns, and further, how these behaviors affect the brain-gut-microbiome (BGM) connections. This study will focus on Mexican and Filipina women because research shows that they encounter a high burden of obesity and exposure to social stressors. Approximately 300 Mexican and Filipina women will be screened and enrolled. They will then provide information about social stressors via food diaries, physical body measures (e.g. waist circumference), questionnaire data regarding diet and eating behaviors, and measures of physical activity. Stool and serum will be collected to analyze microbes and metabolomics, and MRI to assess brain changes in the reward network. Analytic techniques will be used to integrate data from these multiple data sources. This analysis will determine the unique differences associated with ethnicity and social stressors in moderating eating behaviors and dietary patterns. The results of this study will provide new information about a possible pathway whereby social stressors affect behavioral, neurological and microbiome mechanisms related to obesity risk and provide new information in BGM patterns in two understudied ethnic groups. In the long term, this research may suggest possible approaches for intervention that may help reduce inequalities in obesity and related health problems.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
266

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 24, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 21, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

November 16, 2021

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 10, 2025

Status Verified

January 1, 2025

Enrollment Period

3.4 years

First QC Date

October 21, 2021

Last Update Submit

January 8, 2025

Conditions

Keywords

ObeseMexican WomenFilipina WomenOverweightBrain-Gut MicrobiomeMRIMetabolome

Outcome Measures

Primary Outcomes (3)

  • Multimodal Brain Signatures

    Neuroimaging of participants brain via MRI procedure.

    Measured once at Visit 2. Scan lasts about 1.5 hour.

  • Microbiome - Stool

    Measurement of 16S RNA, shotgun metagenomics, and metabolomics via stool specimen.

    Collected twice by the participant at home between Visit 1 and Visit 2, lasting no more than 2 weeks after the first appointment.

  • Microbiome - Blood

    Measurement of 16S RNA, shotgun metagenomics, and metabolomics via blood specimen.

    Collected once at Day1.

Secondary Outcomes (8)

  • Systolic and Diastolic Blood Pressure

    Measured once at Day 1.

  • Questionnaire Data - Diet

    Self-reported by the participant at home between Visit 1 and Visit 2, lasting no more than 2 weeks after the first appointment.

  • Questionnaire Data - Stressors

    Self-reported by the participant at home between Visit 1 and Visit 2, lasting no more than 2 weeks after the first appointment.

  • Anthropometrics - waist & hip circumference

    Measured once at Day 1.

  • Anthropometrics - BMI

    Measured once at Day 1.

  • +3 more secondary outcomes

Other Outcomes (3)

  • Differences in Multimodal Brain Signatures

    Measured at optional follow up visit at 3 and/or 6 month mark. Scan lasts about 1.5 hour.

  • Differences in Microbiome - Stool

    Collected twice by the participant at home before the 3 and/or 6 month follow up appointment, occurring approximately 3 and 6 months after the second (MRI) appointment.

  • Differences in Microbiome - Blood

    Collected once at the 3 and/or 6month follow up appointment, occurring approximately 3 and 6months after the second (MRI) appointment.

Study Arms (2)

Mexican Women

Mexican, premenopausal women ages 18-50.

Filipina Women

Filipina, premenopausal women ages 18-50.

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Participants recruited from the greater Los Angeles Mexican \& Filipina female population.

You may qualify if:

  • Premenopausal females
  • Ages 18-50
  • Mexican or Filipino ancestry
  • BMI 19-40
  • Fluent in English
  • Right-handed

You may not qualify if:

  • Co-Morbidities including but not limited to:
  • Type I diabetes (insulin dependent)
  • Vascular disease
  • Drastic weight loss (more than 10lbs over the preceding 2months)
  • Frequent Strenuous exercise (i.e. marathon runners/heavy weight lifting)
  • Abdominal surgeries including weight loss surgery, or partial/complete resection of the stomach or bowel
  • Untreated thyroid disease
  • Neurological disease
  • Major medical condition that may put the subject at risk or interfere with data collection as determined by the PI/MD
  • Chronic pain
  • Diagnosed DSM IV active psychiatric illness including eating disorders. Must not be active or present for at least 2 years.
  • Use of medications known to affect hunger, satiety, and/or appetite.
  • Unable to safely participate in the MRI (claustrophobia, presence of devices affected by MRI such as pacemakers, neurostimulators, or any metallic foreign body, etc.)
  • Pregnant, lactating, postpartum less than 6mo
  • Women of childbearing age who are not practicing birth control or are planning to get pregnant during the study.
  • +20 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Los Angeles

Los Angeles, California, 90095, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Stool and plasma are collected.

MeSH Terms

Conditions

RacismSocial IsolationObesityOverweight

Condition Hierarchy (Ancestors)

PrejudiceSocial BehaviorBehaviorSocial DiscriminationOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Arpana Gupta, PhD

    The Regents of the University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 21, 2021

First Posted

November 16, 2021

Study Start

August 24, 2021

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

January 10, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

At this time there is no plan to make the de-identified data available for sharing with other researchers.

Locations